Understanding Your BMI and Why It Only Tells Part of the Story
BMI was never designed to measure individual health. It was a statistical tool invented in the 1800s. Here is what it tells you and what it does not.

Body mass index is the most widely used clinical measure of weight status globally, and it is also one of the most frequently misapplied. As an internist, I calculate BMI routinely, but I use it as a starting point for a conversation rather than a verdict. BMI has genuine utility as a population-level screening tool, but applied to an individual patient without context, it misclassifies a meaningful proportion of people, both labeling healthy people as overweight and, more dangerously, reassuring people with significant metabolic risk that their weight is acceptable. Understanding what BMI actually measures, where it breaks down, and what should accompany it in a clinical assessment changes how you interpret your own number.
What BMI Is and Where It Came From
Body mass index is calculated by dividing weight in kilograms by the square of height in meters. The formula was developed in the 1830s by the Belgian mathematician Adolphe Quetelet to describe the statistical distribution of human body proportions in European male populations. It was not designed to measure individual health or body fat. It was designed to describe a population average. The use of Quetelet's index as a clinical tool to categorize individual health risk came much later, driven primarily by insurance industry actuarial data in the mid-20th century.
Current WHO BMI categories are: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese 30 and above. These thresholds are population-derived and carry real predictive value at the extremes: very high BMI is consistently associated with elevated risk of type 2 diabetes, cardiovascular disease, certain cancers, and all-cause mortality. Very low BMI is associated with increased mortality from different causes. The categories in between are where clinical nuance matters most.
Where BMI Fails
It Measures Weight, Not Fat
BMI reflects total body mass relative to height. It cannot distinguish between fat mass and lean mass. Muscle is denser and heavier than fat. A person with significant muscle mass, such as an elite rugby player or a heavily built manual laborer, may have a BMI in the overweight or obese range with excellent metabolic health and very low body fat percentage. Conversely, a person can have a normal BMI with a high proportion of body fat, a pattern called metabolic obesity or "normal weight obesity," which carries cardiovascular and metabolic risk that the BMI obscures entirely.
It Does Not Distinguish Fat Distribution
Where fat is stored matters as much as how much fat there is. Visceral fat, stored around the internal organs of the abdomen, is metabolically active, producing inflammatory cytokines and driving insulin resistance, dyslipidemia, and cardiovascular risk. Subcutaneous fat, stored under the skin, is metabolically less harmful. Two people with identical BMIs and identical total body fat can have very different distributions, one with predominantly visceral fat and high metabolic risk, one with predominantly subcutaneous fat and lower risk. BMI cannot capture this distinction.
It Varies by Ethnicity
The BMI thresholds derived from European populations do not apply equally across ethnicities. People of South and East Asian descent tend to develop cardiometabolic complications at lower BMI values than European populations. For these groups, the WHO has recognized lower BMI thresholds as more appropriate for intervention: overweight is redefined at approximately 23 and obese at 27.5 in many Asian populations. The reverse can also apply: people of some West African ancestry tend to have higher BMI values at equivalent metabolic risk compared to European populations. Using a single global BMI standard misclassifies meaningful proportions of patients across all these groups.
It Does Not Account for Age
Body composition changes with age independent of weight. Muscle mass declines and fat mass tends to increase as a proportion of total body weight through the adult years, a process accelerated after 60. An older adult and a younger adult with identical BMIs may have very different body fat percentages and metabolic risk profiles. In older adults particularly, low BMI is a more significant concern than in middle-aged adults, since low weight in older age is associated with sarcopenia, frailty, and higher mortality.
Sex Differences
Women naturally have a higher percentage of body fat than men at the same BMI, because female physiology requires greater fat reserves for hormonal function and reproductive capacity. The same BMI value reflects different body compositions in men and women, yet the classification thresholds are not sex-differentiated in standard use.
What to Use Instead
JourneyDoctors
Not sure if this applies to you?
Describe your symptoms to Dr. Maya — our AI GP — and get a real clinical response in under a minute. Free to start.
Talk to Dr. MayaWaist Circumference
Waist circumference is a direct measure of abdominal adiposity and is a better predictor of cardiometabolic risk than BMI in most settings. Measurements above 88 cm (35 inches) in women and 102 cm (40 inches) in men indicate elevated risk. These thresholds are also ethnicity-specific: lower thresholds (80 cm for women, 90 cm for men) apply to South and East Asian populations. Waist circumference should be measured at the midpoint between the lower rib margin and the iliac crest, using a flexible tape, after normal expiration.
Waist-to-Height Ratio
The ratio of waist circumference to height has emerged as arguably the best single anthropometric predictor of cardiometabolic risk in population research. A simple rule that has strong epidemiological support: keep your waist circumference to less than half your height. This ratio accounts for height, making it more consistent across populations than waist circumference thresholds alone. It correlates better with visceral fat, insulin resistance, dyslipidemia, and cardiovascular risk than BMI.
Body Composition Measurement
More precise measurement of body fat percentage is available through DEXA scanning (dual-energy X-ray absorptiometry, which also provides bone density), air displacement plethysmography, and bioelectrical impedance analysis (widely available in clinical scales, though less accurate). DEXA is the gold standard but not readily accessible for routine clinical use. Bioelectrical impedance is accessible but sensitive to hydration status. Healthy body fat ranges differ by sex and age: approximately 21 to 33 percent for women, 8 to 19 percent for men, with ranges broadening with age.
Metabolic Markers
Ultimately, the risk that excess weight creates is mediated through metabolic abnormalities. Fasting glucose, HbA1c, lipid panel, blood pressure, and inflammatory markers (CRP) provide direct evidence of metabolic health that BMI cannot. A person with a BMI of 27 and normal metabolic markers has very different clinical risk from a person with the same BMI and elevated fasting glucose, low HDL, high triglycerides, and hypertension, the constellation that defines metabolic syndrome.
What BMI Is Still Good For
BMI remains a useful population screening tool because it is cheap, simple, and reproducible. At the extremes, it reliably identifies people who warrant further evaluation: a BMI above 35 always warrants clinical attention regardless of ethnicity or body composition. It is a reasonable starting point for a clinical conversation. The problem arises when it is used as a final answer rather than an opening question, and when decisions about treatment, surgical candidacy, or insurance coverage are made on BMI alone without the clinical context that changes its meaning.
A Note on Weight Stigma
The clinical literature on weight and health is complicated by weight stigma, both in society and in healthcare settings. People with higher BMI receive different clinical care, are less likely to have symptoms thoroughly investigated, and report more negative interactions with healthcare providers. The goal of clinical assessment should be understanding metabolic health and reducing risk, not labeling people by a number. Waist circumference, metabolic markers, and body composition give more actionable information than BMI and shift the conversation from weight as a moral category to metabolic health as a clinical target.
When to See a Doctor
If you want a meaningful assessment of your metabolic health beyond a BMI number, a full clinical review including waist circumference, fasting glucose, lipid panel, and blood pressure gives a more complete picture. JourneyDoctors internists can review your metabolic markers, contextualize your weight, and advise on evidence-based approaches to improving cardiometabolic health. Consultations start at $19.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of any medical condition.
Get proper care
Ready to speak with a specialist?
If anything in this article sounds familiar, the right next step is a proper evaluation. JourneyDoctors connects you with a specialist in minutes. Consultations from $19.
See a specialist nowFrequently Asked Questions
Is BMI still useful at all?
Yes, as a population screening tool and a rough starting point. It identifies the extremes of weight-related risk reliably. It should not be used as the sole determinant of an individual's metabolic health or treatment decisions, and it should always be supplemented with waist circumference and metabolic markers in clinical practice.
Can you be overweight by BMI but metabolically healthy?
Yes. The concept of "metabolically healthy obesity" is real and well-documented. A person with a BMI in the overweight or class 1 obese range who has normal blood pressure, normal blood glucose, normal lipids, and no significant visceral fat accumulation may have a different risk profile than the BMI category implies. This pattern is more common in younger patients and tends to be unstable over time, with a proportion eventually developing metabolic abnormalities as they age.
What is a healthy waist circumference?
For European populations: below 80 cm (31.5 inches) in women and below 94 cm (37 inches) in men is low risk; above 88 cm (35 inches) in women and 102 cm (40 inches) in men is high risk. For South and East Asian populations: below 80 cm for women and below 90 cm for men. Measuring after normal expiration, at the midpoint between the last rib and the iliac crest, gives the most consistent result.
Does muscle mass affect BMI?
Yes. Because BMI does not distinguish muscle from fat, individuals with significant muscle mass can be classified as overweight or obese by BMI while having a low or normal body fat percentage and excellent metabolic health. This is particularly relevant for athletes, people who do significant resistance training, and manual laborers. For these individuals, waist circumference and body composition assessment are more informative than BMI.
How do I calculate my BMI?
BMI equals weight in kilograms divided by height in meters squared. For example, a person who weighs 80 kg and is 1.75 m tall has a BMI of 80 divided by 3.0625, which equals approximately 26.1. In imperial units, multiply weight in pounds by 703, then divide by height in inches squared. Most health apps and clinical tools calculate this automatically. The result should be interpreted alongside waist circumference and metabolic markers rather than in isolation.
Written by
Dr. James Okafor
Internal Medicine

